01484nam a2200265   45000010005000000100015000050900009000201000041000291010008000702000159000782100083002372150023003202250033003433000086003763300382004626060028008446060027008726060030008996060025009296060026009546060030009807100075010108520011010859950122010967598  a9291681377  a7598  a20030502d2003       y0pory50      ba  aeng  aReport on the risk assessment of PMMA in the framework of the joint action on new synthetic drugsfEuropean Monitoring Centre for Drugs and Drug Addiction  aLuxembourgcOffice for Official Publications of the European Communitiesd2003  a122 p.cil.d21 cm  aEMCDDA - Risk Assessmentsv5  aInformação sobre EMCDDA pode ser encontrada no site: https://www.emcdda.eu.int  aReport on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs. Council decision. Europol-EMCDDA progress report on PMMA and PMA. Review of the pharmacotoxicological data on PMMA. Sociological and criminological evidence on the risks of PMMA. Public health risks of PMMA: epidemiological evidence. Participants in the risk assessment process.  aSAÚDE PÚBLICA91370  aCONSUMO DE DROGA95102  aTOXICODEPENDÊNCIA94612  aTIPOS DE DROGA96299  aUNIÃO EUROPEIA9100  aRELATÓRIO ANUAL9299235  aEUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION - EMCDDA95764  jDRO210  104DRO_210_00000000000000052021-12-1764486910391aDGRSPcDGRSPfDGRSP4486535863kDRO210n2021-12-17o0rMOxoferta